{
    "Trade/Device Name(s)": [
        "BD MAX\u2122 StaphSR",
        "BD Diagnostics BD MAX\u2122 StaphSR Assay"
    ],
    "Submitter Information": "GeneOhm Sciences Canada Inc. (BD Diagnostics)",
    "510(k) Number": "K132822",
    "Predicate Device Reference 510(k) Number(s)": [
        "K120138",
        "K071026"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NQX",
        "OOI"
    ],
    "Summary Letter Date": "September 16, 2013",
    "Summary Letter Received Date": "September 17, 2013",
    "Submission Date": "November 19, 2013",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial susceptibility test powder"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "Staphylococcus aureus DNA",
        "Methicillin-resistant Staphylococcus aureus (MRSA) DNA",
        "mecA gene",
        "mecC gene",
        "nuc gene",
        "SCCmec right-extremity junction (MREJ)"
    ],
    "Specimen Type(s)": [
        "Nasal swab"
    ],
    "Specimen Container(s)": [
        "BD MAX\u2122 StaphSR Sample Buffer Tube"
    ],
    "Instrument(s)/Platform(s)": [
        "BD MAX\u2122 System"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "Fluorogenic target-specific hybridization probes",
        "Automated nucleic acid extraction"
    ],
    "Methodologies": [
        "Qualitative nucleic acid amplification",
        "Automated sample preparation",
        "Molecular detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "System",
        "Instrument",
        "Reagent",
        "Cartridge",
        "Software",
        "Accessory",
        "Consumable",
        "Buffer",
        "Strip",
        "Tube"
    ],
    "Document Summary": "FDA 510(k) summary for BD MAX\u2122 StaphSR automated qualitative PCR assay to detect and differentiate MRSA and S. aureus DNA from nasal swabs using the BD MAX\u2122 System",
    "Indications for Use Summary": "Automated qualitative in vitro diagnostic test for direct detection and differentiation of Staphylococcus aureus (SA) and methicillin-resistant Staphylococcus aureus (MRSA) DNA from nasal swabs in patients at risk for nasal colonization to aid in prevention and control of infections in healthcare settings; not intended for diagnosis or treatment monitoring.",
    "fda_folder": "Microbiology"
}